A novel 8.7-kb mitochondrial genome deletion accurately detects endometriosis in the plasma of symptomatic women

3Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Aim: To evaluate an 8.7-kb mitochondrial DNA (mtDNA) deletion as a potential biomarker of endometriosis. Materials & methods: We tested the diagnostic accuracy of the 8.7-kb deletion real-time PCR assay using 182 prospectively collected blood samples from females presenting with symptoms of endometriosis in a case-control format. Results: The assay differentiated between endometriosis and controls (area under curve: 0.74-0.89) with a statistically significant difference (p < 0.05) in 8.7-kb deletion levels measured for all disease subtypes and stages. No correlation was seen between 8.7-kb deletion levels and participant or specimen age, hormone status or menstrual phase. Conclusion: The diagnostic accuracy of the 8.7-kb deletion for endometriosis suggests potential utility in the clinic to improve patient management.

Cite

CITATION STYLE

APA

Harbottle, A., Maggrah, A., Usher, R., Desa, E., & Creed, J. M. (2020). A novel 8.7-kb mitochondrial genome deletion accurately detects endometriosis in the plasma of symptomatic women. Biomarkers in Medicine, 14(2), 97–107. https://doi.org/10.2217/bmm-2019-0451

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free